Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02270073
Other study ID # MA6526/2-1(DFG)
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 2014
Est. completion date July 2018

Study information

Verified date October 2018
Source Heidelberg University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Background: Mindfulness has its origins in an Eastern Buddhist tradition that is over 2500 years old and can be defined as a specific form of attention that is non-judgemental, purposeful, and focused on the present moment. It has been well established in cognitive behavior therapy in the last decades, while it has been investigated in manualized group settings. Consequently, the demand to investigate mindfulness under effectiveness conditions in trainee therapists has been highlighted.

Methods/Design: To fill in this research gap, the investigators designed the PrOMET-Study. In this study, the investigators will analyze the effects of brief, audio-tape presented, in-session mindfulness interventions conducted by both trainee therapists and their patients at the beginning of individual therapy sessions in a randomized, controlled longitudinal design under effectiveness conditions in a total of 30 trainee therapists and 150 patients in a large outpatient training center. The investigators hypothesize the mindfulness intervention will have positive effects on therapeutic processes and outcome in contrast to a progressive muscle relaxation and a treatment as usual group. The investigators will conduct multilevel modeling to address the nested data structure.

Discussion: The study results could provide important practical implications, as they could inform ideas on how to improve clinical training of psychotherapists that could be implemented very, as there is no need for complex infrastructures or additional time concerning these brief, in-session mindfulness interventions that are directly implemented in treatment sessions.


Description:

Read more »
Read more »

Study Design


Intervention

Behavioral:
Cognitive behavior therapy of trainee therapists
In all three treatment arms, trainee therapists perform a cognitive behavior therapy (CBT) under conditions of the German health care system. This treatment is not a manualized intervention, but rather based on individualized treatment plans that have been developed together with expert supervisors during a five session diagnostic stage. Treatment duration is 25 sessions, while on average every fourth is supervized by an CBT expert therapist.

Locations

Country Name City State
Germany Center for Psychological Psychotherapy - University of Heidelberg Heidelberg Baden Wuerttemberg

Sponsors (4)

Lead Sponsor Collaborator
Heidelberg University University of Applied Sciences Esslingen, University of Trier, University of Zurich

Country where clinical trial is conducted

Germany, 

References & Publications (4)

Blanck P, Perleth S, Heidenreich T, Kröger P, Ditzen B, Bents H, Mander J. Effects of mindfulness exercises as stand-alone intervention on symptoms of anxiety and depression: Systematic review and meta-analysis. Behav Res Ther. 2018 Mar;102:25-35. doi: 10.1016/j.brat.2017.12.002. Epub 2017 Dec 20. — View Citation

Mander J, Blanck P, Neubauer AB, Kröger P, Flückiger C, Lutz W, Barnow S, Bents H, Heidenreich T. Mindfulness and progressive muscle relaxation as standardized session-introduction in individual therapy: A randomized controlled trial. J Clin Psychol. 2018 — View Citation

Mander J, Kröger P, Heidenreich T, Flückiger C, Lutz W, Bents H, Barnow S. The Process-Outcome Mindfulness Effects in Trainees (PrOMET) study: protocol of a pragmatic randomized controlled trial. BMC Psychol. 2015 Jul 17;3(1):25. doi: 10.1186/s40359-015-0082-3. eCollection 2015. — View Citation

Mander, J., Kröger, P., Blanck, P., Call, M., Bents, H., & Heidenreich, T. (2017). Theorie- Praxis-Netzwerke in verhaltenstherapeutischer Ausbildung: Schulung, Selbsterfahrung und Einsatz in der Therapie am Beispiel von Achtsamkeit [Theory- Practice Networks for Training in Behavioral Therapy: Training, Self-Discovery and Integration into Treatment Using Mindfulness as an Example]. Verhaltenstherapie, 27(2), 97-106.

Outcome

Type Measure Description Time frame Safety issue
Other Practice Quality-Mindfulness (PQ-M) Measures presence of therapists and patients during the interventions at beginning of therapy sessions on first treatment day, then on average: after 5 weeks, 15 weeks, 25 weeks and 12-months follow-up
Other General Mindfulness Practice (GMP) Instrument to assess therapists personal mindfulness practice, experience before entering study and intensity of mindfulness application in therapy sessions on first treatment day, then on average: after 5 weeks, 15 weeks, 25 weeks, and 12-months follow-up
Other Therapist Presence Inventory (TPI) Instrument to assess general session presence on average: after 5 weeks, 15 weeks, 25 weeks
Primary Working Alliance Inventory - Short Revised (WAI-SR) The WAI-SR is a self-report of therapeutic alliance measuring Bond, Goals and Tasks in psychotherapy based on feedback of both patients and therapists concerning the current therapy session measured for 25 weeks on weekly basis, starting on first treatment day
Primary Brief Symptom Inventory (BSI) Self-report on general symptom severity of patients on first treatment day, then on average: after 5 weeks, 15 weeks, 25 weeks and 12-months follow-up
Secondary Beck Depression Inventory (BDI) Self-report on depressive symptoms of patients on first treatment day, then on average: after 5 weeks, 15 weeks, 25 weeks and 12-months follow-up
Secondary Inventory of Interpersonal Problems (IIP) Self-report on interpersonal problems of patients on first treatment day, then on average: after 5 weeks, 15 weeks, 25 weeks and 12-months follow-up
Secondary Kentucky Inventory of Mindfulness Skills (KIMS) Self-report on patients and therapists mindfulness abilities on first treatment day, then on average: after 5 weeks, 15 weeks, 25 weeks and 12-months follow-up
Secondary Global Assessment of Functioning (GAF) Therapist perspective on patient´s general symptomatology on first treatment day, then on average: after 5 weeks, 15 weeks, 25 weeks and 12-months follow-up
Secondary Development of Psychotherapists Common Core Questionnaire (DPCCQ) short version Self-report on therapists-variables from therapist perspective on first treatment day, then on average: 15 weeks, and 12-months follow-up
Secondary Scale for the Multiperspective Assessment of General Change Mechanisms in Psychotherapy (SACiP) Instrument to assess general therapeutic change mechanisms on average: after 5 weeks, 15 weeks, 25 weeks and 12-months follow-up
Secondary Beck Anxiety Inventory (BAI) Self-report on anxiety symptoms of patients on first treatment day, then on average: after 5 weeks, 15 weeks, 25 weeks and 12-months follow-up
See also
  Status Clinical Trial Phase
Completed NCT03062150 - Mineralocorticoid Receptor, NMDA Receptor and Cognitive Function in Depression N/A
Completed NCT04352101 - Bupropion Versus Escitalopram on Reward Circuitry and Motivational Deficits Phase 4
Completed NCT02855918 - Blood Biomarkers in Suicidal Behaviour N/A
Recruiting NCT03039387 - Effects of tDCS on Cognitive Control and Emotion Regulation in Depressed Patients N/A
Recruiting NCT02213016 - Effectiveness of Repetitive Transcranial Magnetic Stimulation in Depressed Patients Phase 4
Completed NCT01683539 - Understanding How Cognitive Remediation Works N/A
Completed NCT01636791 - CBT Versus a Return to Work Intervention for Patients With Common Mental Illness in Primary Care Phase 3
Recruiting NCT02237937 - Optimizing Antidepressant Treatment by Genotype-dependent Adjustment of Medication According to the ABCB1 Gene Phase 4
Completed NCT01201148 - Open Pilot Trial of TES for Depression Phase 2
Completed NCT00953108 - Quetiapine Prolong, Escitalopram and Hypothalamic-pituitary-adrenocortical (HPA) Axis Activity in Depressed Patients Phase 3
Completed NCT00711737 - Study of the Changes in Metabolic Parameters in Patients Treated With Escitalopram for Six Months N/A
Terminated NCT00695552 - The Effect of Exercise on Depressive Symptoms in Unmedicated Patients N/A
Terminated NCT01244711 - Open-Label Pilot Study to Examine the Value of Substituting Quetiapine for Benzodiazepines Phase 4
Completed NCT00806143 - Bilateral Versus Monolateral Repetitive Transcranial Stimulation in Depression Phase 4
Completed NCT00532480 - Study of Brain Response to Emotional Pictures Using a fMRI While on Duloxetine Phase 4
Completed NCT00482482 - Yoga in Unipolar and Bipolar Disorders N/A
Completed NCT00466323 - The Effectiveness of FMPO in Improving the Quality of Care for Persons With Severe Mental Illness. N/A
Completed NCT00616759 - The Effect on Cognition of Terminating ECT Induced Seizures With Propofol N/A
Recruiting NCT00209807 - Effect of Escitalopram vs. Reboxetine on Gastro-intestinal Sensitivity of Patients With Major Depressive Disorder Phase 4
Completed NCT00149110 - Chronos: the Use of Chronobiological Treatment in Depression N/A